Qube Research & Technologies (QRT)’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-204
| Closed | -$14.4K | – | 2948 |
|
2025
Q1 | $14.4K | Sell |
204
-178
| -47% | -$12.6K | ﹤0.01% | 2504 |
|
2024
Q4 | $25.1K | Sell |
382
-533
| -58% | -$35K | ﹤0.01% | 2427 |
|
2024
Q3 | $64.6K | Sell |
915
-556
| -38% | -$39.3K | ﹤0.01% | 2331 |
|
2024
Q2 | $97.6K | Buy |
1,471
+1,286
| +695% | +$85.3K | ﹤0.01% | 2250 |
|
2024
Q1 | $12.6K | Buy |
185
+74
| +67% | +$5.02K | ﹤0.01% | 3252 |
|
2023
Q4 | $6.86K | Sell |
111
-1,986
| -95% | -$123K | ﹤0.01% | 3238 |
|
2023
Q3 | $124K | Sell |
2,097
-16,707
| -89% | -$986K | ﹤0.01% | 2162 |
|
2023
Q2 | $170K | Buy |
18,804
+16,065
| +587% | +$145K | ﹤0.01% | 1747 |
|
2023
Q1 | $160K | Sell |
2,739
-897
| -25% | -$52.4K | ﹤0.01% | 1939 |
|
2022
Q4 | $226K | Sell |
3,636
-915
| -20% | -$56.8K | ﹤0.01% | 1695 |
|
2022
Q3 | $257K | Buy |
+4,551
| New | +$257K | ﹤0.01% | 1637 |
|
2022
Q1 | – | Sell |
-198
| Closed | -$13K | – | 2689 |
|
2021
Q4 | $13K | Buy |
198
+144
| +267% | +$9.46K | ﹤0.01% | 2381 |
|
2021
Q3 | $3K | Sell |
54
-1,146
| -96% | -$63.7K | ﹤0.01% | 2091 |
|
2021
Q2 | $74K | Buy |
+1,200
| New | +$74K | ﹤0.01% | 1977 |
|